MedTrace Logo

Fall Risk and Quality of Life: in Individuals With Cancer Treatment Related Peripheral Neuropathy.

NCT06313359 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2025-09-03

No results posted yet for this study

Summary

The purpose of this research is to examine the impact of peripheral neuropathy on fall risk and quality of life in people who had cancer and neuropathy from cancer treatments. The investigators are interested to find out if the participant have any difficulty with thinking, feeling, balancing, or moving around that will contribute to risk for falls or quality of life. Investigators are also interested to see if the participants have any difficulty with doing two activities at the same time, such as walking and texting.

Conditions

  • Peripheral Neuropathy Due to Chemotherapy

Sponsors & Collaborators

  • Texas Woman's University

    lead OTHER

Principal Investigators

  • Priya Karakkattil, PhD · Texas Woman's University

  • Asha Vas, PhD · Texas Woman's University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-30
Primary Completion
2025-12-30
Completion
2026-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06313359 on ClinicalTrials.gov